Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Best Compounded Semaglutide Telehealth Providers 2026: Honest Comparison

By
Published Updated Last reviewed
9 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Legal status / Not FDA approved; not reviewed for safety, effectiveness or quality before marketing [1]
  • Enforcement discretion / Ended for state-licensed pharmacies and physicians after a court ruling on 2025-04-24 [2]
  • Copy rule / FDA restricts routine compounding of essentially-copy products; it does not intend to act against four or fewer such prescriptions a calendar month, and a prescriber may document a significant difference for a patient [2]
  • Adverse events / 990 reports for compounded semaglutide received by FDA as of 2026-05-31, which FDA says likely undercounts [1]

What changed in 2025 and 2026

On 2025-02-21 FDA announced it would stop tolerating the compounding of semaglutide injection that had depended on temporary flexibility [2]. Enforcement discretion for state-licensed pharmacies and physicians ended after a court denied the compounders' injunction request on 2025-04-24; for outsourcing facilities FDA said it would not act until 2025-05-22 [2]. On 2026-04-30 FDA proposed to exclude semaglutide, tirzepatide and liraglutide from the outsourcing bulks list, finding no clinical need; comments were due 2026-06-29 and no final decision has been made [3].

The rules a compounded prescription has to meet

A compounded product must be made for an individual patient on a prescription [2]. It cannot be compounded regularly or in inordinate amounts if it is essentially a copy of a commercially available drug, unless the prescriber documents a change that produces a significant difference for that patient [2]. FDA says it does not intend to act against a compounder filling four or fewer prescriptions of an essentially-copy product in a calendar month; that is an enforcement policy, and a documented significant difference for an individual patient is a separate exception [2].

Adding an ingredient does not automatically change the copy test: semaglutide plus vitamin B12, given by the same route with the amounts of semaglutide and B12 each within 10% of their respective commercial products, may still be essentially a copy [2]. Semaglutide sodium and semaglutide acetate salts are different active ingredients from the approved drug, with no lawful basis for compounding that FDA is aware of [1].

What to check before paying

FDA's warning signs for a telehealth offer include a company that sends medicine that looks different from what was pictured, arrives damaged or lacks instructions for use; does not require screening and a prescription by a licensed doctor; has no licensed doctor available after the medicine arrives; or makes label spelling errors or lists a pharmacy name that might be fraudulent [1]. FDA recommends discarding a multi-dose vial within 28 days of first use, even if medication remains, and not using an injectable GLP-1 drug that arrives warm [1].

Which semaglutide products are FDA approved?

Semaglutide is a GLP-1 receptor agonist. FDA-approved semaglutide products include Ozempic injection and tablets, Rybelsus tablets, and Wegovy injection and tablets [4][5][6][7]. Wegovy injection has weight-management indications for eligible adults and children aged 12 and older, plus indications for cardiovascular risk reduction and noncirrhotic MASH in certain adults; Wegovy tablets have weight-management indications for eligible adults, with no pediatric or MASH indication [8]. Ozempic has no weight-loss indication [9].

HealthRX.com offers compounded semaglutide by prescription.

Frequently asked questions

Is compounded semaglutide legal in 2026?
A state-licensed pharmacy or physician may compound it for an individual patient on a prescription. FDA restricts routine compounding of products that are essentially copies of a commercially available drug, unless the prescriber documents a significant difference for that patient, and says it does not intend to act against four or fewer such prescriptions in a calendar month [2]. FDA's temporary enforcement discretion ended in 2025 [2].
Does adding vitamin B12 make a compounded product different?
Not automatically. A semaglutide plus B12 product given by the same route, with the amounts of semaglutide and B12 each within 10% of their respective commercial products, may still be essentially a copy [2].
Which semaglutide products are FDA approved?
Ozempic injection and tablets, Rybelsus tablets, and Wegovy injection and tablets [4][5][6][7]. Wegovy carries the weight-management indications; Ozempic has none [9][8].

References

  1. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
  2. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA
  3. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on Bulks List | FDA. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on Bulks List | FDA
  4. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
  5. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
  6. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
  7. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
  8. U.S. National Library of Medicine, DailyMed. Wegovy injection and Wegovy tablets (Novo Nordisk) prescribing information. Wegovy injection and Wegovy tablets (Novo Nordisk) label
  9. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
Evidence overview for Best Compounded Semaglutide Telehealth Providers 2026: Honest Comparison